Results 61 to 70 of about 2,311,361 (335)
The aftermath of coronavirus disease of 2019: devastation or a new dawn for nephrology? [PDF]
, 2020 The acute crisis with the coronavirus disease of 2019 (COVID-19) caused by the novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) is the largest biomedical catastrophe of our lifetimes. Like so many other disasters in the past,
Agarwal, Rajiv
core +2 more sources
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Science, 2020 Immune profiling of COVID-19 patients Coronavirus disease 2019 (COVID-19) has affected millions of people globally, yet how the human immune system responds to and influences COVID-19 severity remains unclear. Mathew et al.
P. Arunachalam +30 more
semanticscholar +1 more source
Six-Month Follow-up Chest CT findings after Severe COVID-19 Pneumonia
Radiology, 2021 Background Little is known about the long-term lung radiographic changes in convalescent COVID-19 patients, especially the severe cases. Purpose To prospectively assess pulmonary sequelae and explore the risk factors for lung fibrotic-like changes on six-
Xiaoyu Han +10 more
semanticscholar +1 more source
Science immunology, 2020 Single-cell RNA sequencing of blood immune cells reveals type I interferon–associated hyper-inflammation in severe COVID-19. Cytokine drivers of COVID-19 By carrying out single-cell RNA sequencing analyses on immune cells in the blood, Lee et al.
Jeong Seok Lee +17 more
semanticscholar +1 more source
COVID-19 infection and severe rhabdomyolysis [PDF]
Baylor University Medical Center Proceedings, 2021 Although patients with COVID-19 can have mild nonspecific myalgia and mild elevation of creatinine kinase levels, severe myalgia along with elevation of creatinine kinase levels >10 times the upper normal limit and dark-colored urine indicate an underlying severe rhabdomyolysis.
Vishal, Patel +2 more
openaire +2 more sources
COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. [PDF]
, 2020 Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or
Greenland, John R +3 more
core
Estimation of COVID-19 spread curves integrating global data and borrowing information
, 2020 Currently, novel coronavirus disease 2019 (COVID-19) is a big threat to global health. The rapid spread of the virus has created pandemic, and countries all over the world are struggling with a surge in COVID-19 infected cases.
Lee, Se Yoon +2 more
core +1 more source
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis
Journal of Fungi, 2021 Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease 2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and outcome of such patients are not well described.
Teny M. John, C. Jacob, D. Kontoyiannis
semanticscholar +1 more source
A case of non‐severe COVID‐19 complicated by pulmonary embolism
Respirology Case Reports, 2020 Novel coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 is rapidly spreading worldwide. A typical clinical manifestation of COVID‐19 is pneumonia, which can progress to acute respiratory distress syndrome and ...
Yuto Akiyama +5 more
doaj +1 more source
A Case of COVID-19 Pneumonia in a Young Male with Full Body Rash as a Presenting Symptom [PDF]
, 2020 Background: In December 2019 the coronavirus disease of 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, was identified in Wuhan, China.
Hunt, Madison, Koziatek, Christian
core